共 99 条
[1]
Trapnell BC(2019)Pulmonary alveolar proteinosis Nat Rev Dis Primers 5 16-826
[2]
Nakata K(2020)Pulmonary alveolar proteinosis Respirology 25 816-1035
[3]
Bonella F(2022)Autoimmune pulmonary alveolar proteinosis Am J Respir Crit Care Med 205 1016-1665
[4]
Campo I(2020)Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study Am J Respir Crit Care Med 202 1656-70
[5]
Griese M(2022)Whole lung lavage: treating pulmonary alveolar proteinosis at the time of COVID pandemic Respir Med Case Rep 39 174-501
[6]
Hamilton J(2022)Inhaled sargramostim (recombinant human granulocyte-macrophage colony-stimulating factor) for COVID-19-associated acute hypoxemia: results of the phase 2, randomized, open-label trial (iLeukPulm) Mil Med 42 57-762
[7]
Jouneau S(2023)A case report of Covid-19 in an autoimmune pulmonary alveolar proteinosis: an association in tune with the times! Respir Med Case Rep 15 497-239
[8]
Ménard C(2020)Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis—a six month phase II randomized study with 24 months of follow-up Orphanet J Rare Dis 402 752-373
[9]
Lederlin M(2014)Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis J Immunol Methods 37 231-1443
[10]
McCarthy C(2014)Serum markers in patients with idiopathic pulmonary alveolar proteinosis Zhonghua Jie He He Hu Xi Za Zhi 177 369-e125